Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma

Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma

Item
http://www.wikidata.org/entity/Q36509109
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesDNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma.Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.MiR-30e-UCP2 pathway regulates alcoholic hepatitis progress by influencing ATP and hydrogen peroxide expression.Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer.Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway.The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.A miRNA Combination as Promising Biomarker for Hepatocellular Carcinoma Diagnosis: A Study Based on Bioinformatics AnalysisRole of miR-223 in the pathophysiology of liver diseasesGenome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
P2860

Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma

Item
http://www.wikidata.org/entity/Q36509109
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma
@ast
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma
@en
type
label
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma
@ast
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma
@en
prefLabel
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma
@ast
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma
@en
P2093
P2860
P304
P31
P356
10.1016/J.AJPATH.2015.10.003
P407
P433
P478
P50
P577
P5875
P698
P921
P932